ATDBio was established to provide high quality oligonucleotides to scientists around the world. ATDBio oligonucleotides are used successfully in academic and commercial research in the fields of...
Nanoprobes was founded to develop the most sensitive reagents and technology for detecting biological molecules. Our unique gold labeling technology uses chemically cross-linked metal clusters and...
Nanotechnology Victoria ("NanoVic"), Monash University, and Swinburne University of Technology completed an agreement in December 2004 for joint investment in new equipment to make nanoarrays for the...
http://www.azonano.com/article.aspx?ArticleID=1274 | 21 Jun 2005
A collaborative group of DuPont-led scientists have discovered an innovative way to advance electronics applications through the use of DNA that sorts carbon nanotubes. Posted December 2 2003
http://www.azonano.com/article.aspx?ArticleID=249 | 3 Dec 2003
Advances in medical nanotechnology are likely to be used in biomedical applications for space projects. This article looks at medical diagnostics, biochips, lab on a chip systems, medical sensors,...
http://www.azonano.com/article.aspx?ArticleID=1176 | 12 Apr 2005
Nanoparticles made of metals such as gold or iron oxide show tremendous promise as contrast agents for molecular imaging, but turning promise into clinical utility requires adding tumor targeting...
http://www.azonano.com/news.aspx?newsID=5288 | 8 Nov 2007
Metal nanoparticles have radically different electronic, optical and magnetic
properties from their larger states, which makes them useful as materials in
new, ultra-small devices such as...
http://www.azonano.com/news.aspx?newsID=13036 | 6 Aug 2009
A new method of manufacturing short, single-stranded DNA molecules can solve many of the problems associated with current production methods. The new method, which is described in the scientific...
http://www.azonano.com/news.aspx?newsID=27513 | 3 Jun 2013
Researchers have significantly advanced methods to improve the speed and accuracy of genomic synthesis
http://www.azonano.com/article.aspx?ArticleID=170 | 20 Nov 2003
Inc., an RNA interference company developing novel therapeutics in multiple
disease areas, today announced that Bob D. Brown, Ph.D., senior vice president
http://www.azonano.com/news.aspx?newsID=8260 | 22 Oct 2008